bupropion has been researched along with Abnormalities, Drug-Induced in 5 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Women who were pregnant or planning a pregnancy and taking bupropion were enrolled in the study." | 7.73 | Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. ( Boshier, A; Chun-Fai-Chan, B; Einarson, A; Fayez, I; Kalra, S; Koren, G; Shakir, S; Voyer-Lavigne, S, 2005) |
| " Exposure categories included first-trimester bupropion alone or in combination with other antidepressants, first-trimester antidepressants other than bupropion, and no exposure to any antidepressant at any time from 2 months prior to pregnancy through delivery." | 3.80 | First-trimester exposure to bupropion and risk of cardiac malformations. ( Kerr, S; Louik, C; Mitchell, AA, 2014) |
| "Women who were pregnant or planning a pregnancy and taking bupropion were enrolled in the study." | 3.73 | Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. ( Boshier, A; Chun-Fai-Chan, B; Einarson, A; Fayez, I; Kalra, S; Koren, G; Shakir, S; Voyer-Lavigne, S, 2005) |
| "When considering treating perinatal depression with a drug indicated for the treatment of depression, the major concerns are whether the drug increases the risks of teratogenicity, pregnancy complications, poor neonatal adaptation, or neurodevelopmental disorders." | 2.58 | Pharmacotherapy for Perinatal Depression. ( Albertini, ES; Ernst, C; Fersh, ME; Habib, S; Khan, SJ; Lusskin, SI, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KN | 1 |
| Lind, JN | 1 |
| Simeone, RM | 1 |
| Bobo, WV | 1 |
| Mitchell, AA | 2 |
| Riehle-Colarusso, T | 1 |
| Polen, KN | 1 |
| Reefhuis, J | 1 |
| Lusskin, SI | 1 |
| Khan, SJ | 1 |
| Ernst, C | 1 |
| Habib, S | 1 |
| Fersh, ME | 1 |
| Albertini, ES | 1 |
| Louik, C | 1 |
| Kerr, S | 1 |
| Chun-Fai-Chan, B | 1 |
| Koren, G | 1 |
| Fayez, I | 1 |
| Kalra, S | 1 |
| Voyer-Lavigne, S | 1 |
| Boshier, A | 1 |
| Shakir, S | 1 |
| Einarson, A | 1 |
| Tucker, WE | 1 |
1 review available for bupropion and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Pharmacotherapy for Perinatal Depression.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Antidepressive Agents, Tricyclic; Autism Spectru | 2018 |
4 other studies available for bupropion and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Bupropion; Case-Control Studies; Child; Female; Huma | 2020 |
First-trimester exposure to bupropion and risk of cardiac malformations.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antidepressive Agents, Second-Generation; Bupropion; | 2014 |
Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Antidepressive Agents, Second-Generation; Birth | 2005 |
Preclinical toxicology of bupropion: an overview.
Topics: Abnormalities, Drug-Induced; Animals; Antidepressive Agents; Bupropion; Central Nervous System; Chem | 1983 |